Holen Sie sich die Stockscreener-App
2.67
0.75%
0.02
Handel nachbörslich:
2.67
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
SG Americas Securities LLC Acquires 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences appoints Bernd Brust as CEO - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire
Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
MRVI Set to Host Global Bioproduction Conference Call | MRVI Stock News - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World
Maravai LifeSciences names Bernd Brust as new CEO By Investing.com - Investing.com South Africa
Maravai Lifesciences Appoints Bernd Brust As CEO & Member Of Its Board Of Directors - MarketScreener
Maravai LifeSciences Names Bernd Brust as CEO - marketscreener.com
Maravai LifeSciences (MRVI) Names Bernd Brust as New CEO | MRVI Stock News - GuruFocus
Maravai Lifesciences Appoints Bernd Brust as New CEO - TipRanks
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Off - GuruFocus
Maravai LifeSciences names Bernd Brust as new CEO - Investing.com Australia
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors | MRVI Stock News - GuruFocus
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors - GlobeNewswire
Life Sciences Leader Maravai Taps Industry Veteran Bernd Brust as CEO to Accelerate Growth in Genomic Medicine - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Two Sigma Investments LP - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.37 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire
Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 8.5% – Time to Buy? - Defense World
Jane Street Group LLC Cuts Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Quantoom Biosciences and TriLink BioTechnologies Sign a Supply and License Agreement - Insider Monkey
TriLink and Quantoom partner to expand global vaccine access By Investing.com - Investing.com South Africa
MRVI: TriLink BioTechnologies Partners with Quantoom for Enhanced mRNA Production | MRVI Stock News - GuruFocus
TriLink and Quantoom partner to expand global vaccine access - Investing.com Australia
Maravai's TriLink, Quantoom Sign License, Supply Agreement - marketscreener.com
Leading COVID-19 Vaccine Technology CleanCap Expands Global Access Through Quantoom Partnership - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World
ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Announces Shareholder Meeting Results - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World
Maravai Lifesciences Holds Annual Shareholders Meeting - TipRanks
Maravai LifeSciences Announces Shareholder Meeting Results By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Purchases Shares of 66,443 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
CORRECTION -- Maravai LifeSciences Releases 2024 Sustainability Report | MRVI Stock News - GuruFocus
Maravai LifeSciences Releases 2024 Sustainability Report Highlighting Product Innovation, Governance Enhancements, and Commitment to Sustainable Growth - Nasdaq
CORRECTIONMaravai LifeSciences Releases 2024 Sustainability Report - The Manila Times
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire
Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan
Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire
Maravai LifeSciencesReleases 2024 Sustainability Report - The Manila Times
Maravai LifeSciences Sustainability Report: 49 New Products and 10X GMP Manufacturing Expansion Drive Growth - Stock Titan
Northern Trust Corp Buys 53,474 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Revolutionary mRNA Synthesis Kit Achieves 2X Yield, 85% Lower dsRNA: TriLink's Game-Changing Launch - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges - TipRanks
Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
0.68%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):